{name}
{subtitle}
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
~73 mi. (Bluffton, South Carolina, +233 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
S0820, Adenoma and Second Primary Prevention Trial
city
~73 mi. (Bluffton, South Carolina, +616 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
city
~73 mi. (Bluffton, South Carolina, +224 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
condition
Hypopharyngeal Carcinoma, +3 more conditions
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +3 more types
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
city
~73 mi. (Bluffton, South Carolina, +413 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
drug
ipilimumab, +2 more drugs
drug type
immunotherapy, +1 more type
Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
city
~73 mi. (Bluffton, South Carolina, +556 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
biomarker
CD19 Expression, +2 more biomarkers
drug
ibrutinib, +2 more drugs
drug type
chemotherapy, +2 more types
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~73 mi. (Bluffton, South Carolina, +954 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
city
~73 mi. (Bluffton, South Carolina, +388 more cities)
facility
Saint Joseph's/Candler - Bluffton Campus
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +2 more types